Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 29;10(19):4517.
doi: 10.3390/jcm10194517.

Therapeutic and Reconstructive Management Options in Scleroderma (Morphea) en Coup de Sabre in Children and Adults. A Systematic Literature Review

Ewelina Ulc  1 , Lidia Rudnicka  1 , Anna Waśkiel-Burnat  1 , Olga Warszawik-Hendzel  1 , Anna Niemczyk  1 , Małgorzata Olszewska  1
Affiliations
Review

Therapeutic and Reconstructive Management Options in Scleroderma (Morphea) en Coup de Sabre in Children and Adults. A Systematic Literature Review

Ewelina Ulc et al. J Clin Med. .

Abstract

Scleroderma (morphea) en coup de sabre is a localized subtype restricted to the frontoparietal region of the head. Current treatment paradigms rely on low levels of evidence, primarily case reports and case series-supported by expert opinions. The aim of this article was to systematically analyze current data related to the treatment of localized scleroderma en coup de sabre. The databases Scopus, PubMed, and EBSCO were searched for all reports discussing the treatment of localized scleroderma en coup de sabre. The keywords en coup de sabre, "facial linear scleroderma", and "morphea linearis", combined with "treatment" or "therapy" were used as search terms. A total of 34 articles analyzed treatment outcomes for patients with localized scleroderma en coup de sabre including 4 retrospective cohort studies, 2 prospective cohort studies, 4 case series, and 24 case reports, representing a total of 69 patients (38 children and 31 adults). Methotrexate was the most commonly investigated treatment (26 patients) with a highest response rate (26/26, 100%). Other treatments included systemic glucocorticosteroids (nine patients), followed by UVA1 (four patients), mycophenolate mofetil (two patients), hydroxychloroquine (five patients), abatacept (two patients), tocilizumab (three patients), cyclosporine (one patient), interferon gamma (one patient), PUVA therapy (two patients), NB-UVB therapy (one patient), and pulsed dye laser (one patient). Reconstructive and surgery treatment was successfully used for lesions with settled disease activity to improve the cosmetic aspect of the lesions. Conclusion: methotrexate is the most often-studied treatment and reported good clinical outcomes in children and adults with localized scleroderma en coup de sabre.

Keywords: cyclosporine; hydroxychloroquine; methotrexate; morphea; scleroderma; therapy; tocilizumab; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA Flowchart.
See this image and copyright information in PMC

References

    1. Tollefson M.M., Witman P.M. En coup de sabre morphea and Parry-Romberg syndrome: A retrospective review of 54 patients. J. Am. Acad. Dermatol. 2007;56:257–263. doi: 10.1016/j.jaad.2006.10.959. - DOI - PubMed
    1. Rattanakaemakorn P., Jorizzo J.L. The efficacy of methotrexate in the treatment of en coup de sabre (linear morphea subtype) J. Dermatolog Treat. 2018;29:197–199. doi: 10.1080/09546634.2017.1341615. - DOI - PubMed
    1. Khamaganova I. Progressive Hemifacial Atrophy and Linear Scleroderma en coup de sabre: A Spectrum of the Same Disease? Front. Med. 2017;4:258. doi: 10.3389/fmed.2017.00258. - DOI - PMC - PubMed
    1. Mears K.A., Servat J.J., Black E.H. Linear scleroderma en coup de sabre affecting the upper eyelid and lashes. Graefes Arch. Clin. Exp. Ophthalmol. 2012;250:1097–1099. doi: 10.1007/s00417-011-1911-6. - DOI - PubMed
    1. Kreuter A., Mitrakos G., Hofmann S.C., Lehmann P., Sticherling M., Krieg T., Lahner N., Tigges C., Hunzelmann N., Moinzadeh P. Localized Scleroderma of the Head and Face Area: A Retrospective Cross-sectional Study of 96 Patients from 5 German Tertiary Referral Centres. Acta Derm. Venereol. 2018;98:603–605. doi: 10.2340/00015555-2920. - DOI - PubMed